breast cancer

Showing 15 posts of 167 posts found.

roche

FDA grants breast cancer approval to Roche’s Perjeta/Herceptin combo therapy

December 21, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche has announced that the FDA has granted approval to Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and a (Perjeta-based) …

800px-cancer_cells_1

University of Virginia researchers identify new target in triple-negative breast cancer

November 28, 2017
Manufacturing and Production, Research and Development University of Virginia, breast cancer, pharma, triple-negative breast cancer

Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive …

NICE refuses Eisai’s breast cancer drug in new indication

November 28, 2017
Manufacturing and Production, Sales and Marketing Cancer, Eisai, Halaven, NICE, breast cancer, pharma

NICE has announced that it has rejected Eisai’s Halaven (eribulin) through draft guidance advising not to use the drug in …

shutterstock_187433765

Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds

November 21, 2017
Manufacturing and Production, Research and Development Cancer, breast cancer, pharma

A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …

shutterstock_187433765

Breast cancer recurrence can occur up to 20 years after treatment, report shows

November 10, 2017
Medical Communications, Research and Development Cancer, breast cancer, pharma, tamoxifen

New findings from the Early Breast Cancer Trialists’ Collaborative Group have demonstrated that oestrogen receptor-positive (ER-positive) breast cancer is able …

nhs_sign

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

shutterstock_206748499

17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows

November 8, 2017
Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer

At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …

novartis_outside_1

Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time

November 8, 2017
Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …

mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017
Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

rocherooflr

FDA awards Roche priority review in HER2-positive breast cancer

October 2, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical

Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …

astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

Novartis gets EU nod for potential blockbuster breast cancer drug

August 24, 2017
Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical

Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …

800px-cancer_cells_1

Chemotherapy can spread breast cancer to lungs, study finds

August 9, 2017
Research and Development Cancer, breast cancer, life sciences, lung cancer, pharma, pharmaceutical

Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight …

breast_cancer

Puma Biotech’s breast cancer drug gets FDA committee nod

May 25, 2017
Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib

Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …

Novartis secures first-line FDA approval in breast cancer indication

March 14, 2017
Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer

The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …

Latest content